Roche launches AXELIOS 1, a transformative next-generation sequencing platform: Basel Tuesday, June 30, 2026, 10:00 Hrs [IST] Roche, a healthcare company, announced the launch of ...
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome sequencing has been set. Think of all the things that can be done in four ...
A hot potato: Next-generation DNA sequencing (NGS) faces mounting scrutiny over its cyber vulnerabilities. While NGS has revolutionized fields ranging from cancer diagnostics to infectious disease ...
A landmark alliance of DNA experts across Europe signals the start of an unprecedented effort to build a continent-wide ...
AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes ...
Medical Device Network on MSN

Roche launches Axelios 1 sequencing platform

The launch was supported by collaborations with institutions such as the Hartwig Medical Foundation and Broad Clinical Labs.